Matrix Metalloproteinase‐13 Is an Unfavorable Prognostic Factor in Chordoma by Digesting Growth Inhibitory Collagens
Open Access
- 19 February 2026
- journal article
- Published by Wiley in Cancer Medicine
- Vol. 15 (2) , e71662
Abstract
Objective: Chordomas are low‐grade but invasive tumors with limited therapies. Some conventional chordomas exhibit cartilage‐like extracellular matrix (ECM). This study examined the expression and clinical significance of collagenases in chordomas. Methods: Brachyury‐positive primary chordoma tissues were analyzed by immunohistochemistry for matrix metalloproteinase (MMP)13, MMP9, and cathepsin K, and by immunofluorescence for MMP13 and MMP9. ECM phenotype was categorized using safranin‐O staining, where safranin‐O marks cartilage‐like ECM. We compared MMP13 expression scores and progression‐free survival (PFS) between safranin‐O‐negative and ‐positive groups. Collagenase gene expression and protein localization in JHC7 cells were analyzed by quantitative PCR and immunocytochemistry, respectively. Collagen digestion activity was evaluated using fluorescein isothiocyanate–labeled type II collagen (COL2) in the presence or absence of an MMP13‐specific inhibitor. Cell growth was evaluated in the presence of type I collagen (COL1) or COL2. Results: Safranin‐O negative chordomas had shorter PFS than safranin‐O positive chordomas ( p = 0.016). MMP13 was expressed in human chordoma tissues and JHC7 cells; the MMP13 expression score was higher in safranin‐O‐negative chordomas than in safranin‐O‐positive chordomas ( p = 0.018). JHC7 cells digested COL2, and digestion was partially but significantly inhibited by an MMP13‐specific inhibitor ( p < 0.05). COL2 inhibited the growth of JHC7 cells more strongly than COL1 in a dose‐dependent manner ( p < 0.01). Conclusions: MMP13 may promote aggressive behavior in chordoma by degrading growth‐inhibitory COL2‐rich ECM. These data support MMP13 as a potential unfavorable prognostic marker and therapeutic target in chordoma.Keywords
This publication has 41 references indexed in Scilit:
- Matrix Gene Expression Analysis and Cellular Phenotyping in Chordoma Reveals Focal Differentiation Pattern of Neoplastic Cells Mimicking Nucleus Pulposus DevelopmentThe American Journal of Pathology, 2001
- Chordoma: incidence and survival patterns in the United States, 1973–1995Cancer Causes & Control, 2001
- Expression of cathepsin K in chordomaHuman Pathology, 2000
- Matrix metalloproteinases in tumor invasionCellular and Molecular Life Sciences, 2000
- Collagen II Is Essential for the Removal of the Notochord and the Formation of Intervertebral DiscsJournal of Cell Biology, 1998
- Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage.Journal of Clinical Investigation, 1996
- Chondrocyte Differentiation1995
- The collagen substrate specificity of rat uterus collagenase.Journal of Biological Chemistry, 1983
- Prognostic factors in chondrosarcoma of bone.A clinicopathologic analysis with emphasis on histologic gradingCancer, 1977
- Chordomas and cartilaginous tumors at the skull baseCancer, 1973